← Back to all trials
Completed
NCT04560660
Ketamine-enhanced Prolonged Exposure Therapy in PTSD
Conditions: PTSD
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 73
Sponsor: VA Office of Research and Development
Location: Minneapolis VA Health Care System, Minneapolis, MN Minneapolis Minnesota
Summary
The purpose of this study is to test the safety and efficacy of repeated doses of ketamine as compared to placebo to reduce symptoms of Posttraumatic Stress Disorder (PTSD) among Veteran receiving Prolonged Exposure Therapy.
Eligibility Criteria
Inclusion Criteria:
* male or female Veterans between the ages of 18 and 75 years
* diagnosis of PTSD
* ability to provide written informed consent
Exclusion Criteria:
* females who are currently pregnant or breastfeeding
* current high risk for suicide
* history of moderate/severe head injury
* history of psychosis
* current episode of mania/hypomania
* severe substance and/or alcohol use disorder in the last 6 months
Source: ClinicalTrials.gov (NCT04560660). StuddyBuddy aggregates publicly available trial information.